CHRS vs JNJ: Which Stock is Better?
Side-by-side comparison of Coherus BioSciences Inc and Johnson & Johnson in 2026
CHRS
Coherus BioSciences Inc
—
JNJ
Johnson & Johnson
$248.82
Key Metrics Comparison
| Metric | CHRS | JNJ | Winner |
|---|---|---|---|
| Market Cap | $223.66M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CHRS
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHRS or JNJ a better investment?
Comparing CHRS and JNJ: Coherus BioSciences Inc has a market cap of $223.66M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHRS and JNJ?
CHRS (Coherus BioSciences Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHRS or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHRS or JNJ?
Both CHRS and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CHRS or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CHRS or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $223.66M for CHRS.
Should I buy CHRS or JNJ in 2026?
Both CHRS and JNJ have investment merit. CHRS trades at $N/A while JNJ trades at $248.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHRS and JNJ stock?
Key differences: Market Cap ($223.66M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CHRS or JNJ in 2026?
The choice between CHRS and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CHRS and JNJ?
CHRS (Coherus BioSciences Inc) has a market cap of $223.66M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.